Limitations of creatinine as a filtration marker in glomerulopathic patients.
about
Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney diseaseSerum cystatin C concentration as a marker of acute renal dysfunction in critically ill patientsCurrent Trends of Renal Impairment in Multiple MyelomaRecommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeMeasurement of renal function in patients with chronic kidney diseaseEstimating glomerular filtration rate in older peopleBiomarkers in chronic kidney disease, from kidney function to kidney damageDetermination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humansIndividualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic reviewSymmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis.Renal functional reserve compared in haemolytic uraemic syndrome and single kidney.Serum cystatin C is a potential endogenous marker for the estimation of renal function in male gout patients with renal impairment.Inaccuracy of glomerular filtration rate estimation from height/plasma creatinine ratioSerum cystatin C as an endogenous marker of the renal function--a review.Imprecision of creatinine-based GFR estimates in uninephric kidney donors.Role of cystatin C and renal resistive index in assessment of renal function in patients with liver cirrhosisAssociation Between Serum Cystatin C and Creatinine in Chronic Kidney Disease Subjects Attending a Tertiary Health Care CentreEffect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safetyA simple method to detect recovery of glomerular filtration rate following acute kidney injuryMeasures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study.HLA matching assessed from early graft function.Visualization of renal medullary hyperattenuation at unenhanced CT: what is the effect of furosemide administration?Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in BrazilComparison of two methods for carboplatin dosing in children with retinoblastoma.Effect of carbonic anhydrase inhibitors on glomerular filtration rate in diabetic nephropathy.Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.Clinical usefulness of serum cystatin C as a marker of renal function.Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onsetFalse estimates of elevated creatinine.Comparison of serum creatinine and serum cystatin C as biomarkers to detect sepsis-induced acute kidney injury and to predict mortality in CD-1 miceThe influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.The effect of famotidine on renal function in patients with renal insufficiency.Significant association between renal function and amyloid-positive area in renal biopsy specimens in AL amyloidosisComparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function.Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.Estimating the glomerular filtration rate. Dos and don'ts for assessing kidney function.Normalization of urinary biomarkers to creatinine during changes in glomerular filtration ratePharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function.Significant differences when using creatinine, modification of diet in renal disease, or cystatin C for estimating glomerular filtration rate in ICU patients.Serum cystatin C levels to predict serum concentration of digoxin in Japanese patients.
P2860
Q24187199-D9387DF2-96B8-4532-ADFD-3BB07B124E4CQ24812122-E62E0B31-9EFA-484C-A72E-0381D0A78883Q26740444-F105928A-C2B0-4264-AC97-B5571E0A6352Q26767011-F00C8C63-02CC-4F2B-80A8-90E869B03606Q26853698-509348CB-7E58-43C4-8B4F-38DB2FF7F0A2Q26860026-258B6AAD-1F1D-424B-AE38-37793BE91558Q28087304-6EC89CE1-2D80-4A21-8FDD-CD98C24EBD3AQ28262338-7DD83664-53F7-4647-85D9-CFEB330CF937Q28543876-B75E6435-0DF0-4259-9A86-F847FF66D83FQ33246409-B4A76148-EEBF-4E77-B3F3-9A9D4483CB35Q33409170-1DD73B55-3659-4B26-A33E-8DC6557A87DEQ33565394-0FC8093F-776F-4050-BCFB-D6B6EADC80C2Q33624602-A507A35F-EB0B-4758-9F4C-25AB769B6965Q33658748-0034A6E0-2EBC-40FE-9A0E-32378B392DD0Q33684032-0B91CBD8-0CA2-4898-BA10-6E78DAD33333Q33718306-6B6E66F8-52C0-4BA1-A351-D15BEBC80742Q33741494-D6F92115-42AC-40F0-ABC3-CEDE90191068Q33750603-65C270D5-6DF0-44A3-8B02-0D7D05341748Q33757893-49ECA2B7-1421-4435-8558-24B00811C07FQ33956740-A38AB85F-8815-4C3E-8EA5-663E49E5AA63Q34024682-D94D6385-E618-42C2-BC3B-9B891BC16EB7Q34028732-19FBC47C-AD08-48EB-A6BC-F330CFA1FC83Q34055914-AF49EDA7-2550-4501-9956-841CC653E086Q34065022-F37C5D3E-4FC3-4707-BBAE-6246CF3B4544Q34068927-072808A1-FC37-442F-8BA2-C7FD7ECDB156Q34079762-CF808166-7EFB-4FE3-9572-79B6589023C3Q34161893-054B2DF0-9CA7-4305-94FE-7672EF784790Q34193127-A353DBDC-F807-4722-A366-FDC0AE8C8196Q34284957-BE72A39A-9C03-47B9-864A-2164B103E2D2Q34355926-3A2A06E5-F7E8-4C6A-BEF8-78CEA0D809B8Q34403128-4E1C1F80-3A66-4FBD-A88A-6AE4C6B198A1Q34416850-8918669D-85D6-4017-A3E9-BCC4CAA5E7C3Q34420452-ECEFFDE0-D959-4F2C-B9EF-BE7919113C0FQ34448041-309C117B-EC4B-4913-8929-357F7CA9CB75Q34489684-7C51CB80-F6F5-4BB9-BB2C-F100822EA940Q34490431-6BD3549C-EBB1-4C5C-B5C0-244C7BA24CDEQ34514525-67F409CA-D4D6-41CB-A878-607FCEC6E275Q34559347-22EAD732-0AEC-4FD2-AA2A-396070A1BC26Q34577344-4FFBC0AB-953D-4D4A-99A6-DBD37C0F1327Q34664889-0DAC6362-12B8-40DA-A89E-98B15F63A6E6
P2860
Limitations of creatinine as a filtration marker in glomerulopathic patients.
description
1985 nî lūn-bûn
@nan
1985 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Limitations of creatinine as a filtration marker in glomerulopathic patients.
@ast
Limitations of creatinine as a filtration marker in glomerulopathic patients.
@en
Limitations of creatinine as a filtration marker in glomerulopathic patients.
@nl
type
label
Limitations of creatinine as a filtration marker in glomerulopathic patients.
@ast
Limitations of creatinine as a filtration marker in glomerulopathic patients.
@en
Limitations of creatinine as a filtration marker in glomerulopathic patients.
@nl
prefLabel
Limitations of creatinine as a filtration marker in glomerulopathic patients.
@ast
Limitations of creatinine as a filtration marker in glomerulopathic patients.
@en
Limitations of creatinine as a filtration marker in glomerulopathic patients.
@nl
P2093
P356
P1433
P1476
Limitations of creatinine as a filtration marker in glomerulopathic patients.
@en
P2093
P2888
P304
P356
10.1038/KI.1985.205
P407
P577
1985-11-01T00:00:00Z
P6179
1042469641